Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.

Dementia is one of the most debilitating symptoms of Parkinson's disease. A recent longitudinal study suggests that up to 80% of patients with Parkinson's disease will eventually develop dementia. Despite its clinical importance, the development of dementia is still difficult to predict at early stages. We previously identified olfactory dysfunction as one of the most important indicators of cortical hypometabolism in Parkinson's disease. In this study, we investigated the possible associations between olfactory dysfunction and the risk of developing dementia within a 3-year observation period. Forty-four patients with Parkinson's disease without dementia underwent the odour stick identification test for Japanese, memory and visuoperceptual assessments, (18)F-fluorodeoxyglucose positron emission tomography scans and magnetic resonance imaging scans at baseline and 3 years later. A subgroup of patients with Parkinson's disease who exhibited severe hyposmia at baseline showed more pronounced cognitive decline at the follow-up survey. By the end of the study, 10 of 44 patients with Parkinson's disease had developed dementia, all of whom had severe hyposmia at baseline. The multivariate logistic analysis identified severe hyposmia and visuoperceptual impairment as independent risk factors for subsequent dementia within 3 years. The patients with severe hyposmia had an 18.7-fold increase in their risk of dementia for each 1 SD (2.8) decrease in the score of odour stick identification test for Japanese. We also found an association between severe hyposmia and a characteristic distribution of cerebral metabolic decline, which was identical to that of dementia associated with Parkinson's disease. Furthermore, volumetric magnetic resonance imaging analyses demonstrated close relationships between olfactory dysfunction and the atrophy of focal brain structures, including the amygdala and other limbic structures. Together, our findings suggest that brain regions related to olfactory function are closely associated with cognitive decline and that severe hyposmia is a prominent clinical feature that predicts the subsequent development of Parkinson's disease dementia.

[1]  T. Kobayakawa,et al.  Smell identification in Japanese Parkinson's disease patients: using the odor stick identification test for Japanese subjects. , 2008, Internal medicine.

[2]  D. Aarsland,et al.  The epidemiology of dementia associated with Parkinson disease , 2010, Journal of the Neurological Sciences.

[3]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[4]  Y. Itoyama,et al.  Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[5]  K. Davis,et al.  The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. , 1983, Psychopharmacology bulletin.

[6]  R. Doty,et al.  Olfactory dysfunction in parkinsonism , 1988, Neurology.

[7]  Saho Ayabe-Kanamura,et al.  Development of a smell identification test using a novel stick-type odor presentation kit. , 2006, Chemical senses.

[8]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[9]  이필휴 A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies , 2007 .

[10]  A. Petrie,et al.  Regional differences in the severity of Lewy body pathology across the olfactory cortex , 2009, Neuroscience Letters.

[11]  P. Hof,et al.  Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease , 2003, Acta Neuropathologica.

[12]  J. Blass,et al.  Inherent Abnormalities in Energy Metabolism in Alzheimer Disease: Interaction with Cerebrovascular Compromise , 2000, Annals of the New York Academy of Sciences.

[13]  V. Preedy,et al.  Unified Parkinson's Disease Rating Scale , 2010 .

[14]  H. Shill,et al.  Defining mild cognitive impairment in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[15]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[16]  A. Lees,et al.  EFFECT OF L-DOPA ON COURSE OF PARKINSON'S DISEASE , 1984, The Lancet.

[17]  D. Maraganore,et al.  Levodopa therapy and survival in idiopathic Parkinson's disease , 1993, Neurology.

[18]  M. Esiri,et al.  Alpha‐synuclein pathology in the olfactory pathways of dementia patients , 2007, Journal of anatomy.

[19]  L. Moran,et al.  Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[20]  Y. Itoyama,et al.  Illusory misidentifications and cortical hypometabolism in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[21]  N. Kumar,et al.  The Sydney Multicenter Study of Parkinson's Disease: The Inevitability of Dementia at 20 years , 2009 .

[22]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[23]  P. Moberg,et al.  Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[24]  Y. Itoyama,et al.  Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour , 2009, Brain : a journal of neurology.

[25]  K. Fiedler,et al.  Olfactory Impairment Predicts Brain Atrophy in Parkinson's Disease , 2009, The Journal of Neuroscience.

[26]  C. Jack,et al.  Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. , 2010, Brain : a journal of neurology.

[27]  I. McKeith,et al.  Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  G. Halliday,et al.  The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.

[29]  R. Albin,et al.  Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  M. J Firbank,et al.  Regional cerebral blood flow in Parkinson's disease with and without dementia , 2003, NeuroImage.

[31]  M. Emre Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.

[32]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[33]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[34]  G. Halliday,et al.  Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. , 2002, Brain : a journal of neurology.

[35]  R. Doty,et al.  Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[36]  D. Burn,et al.  Parkinson’s Disease Dementia , 2020, Language in Dementia.

[37]  Joon-Kee Yoon,et al.  A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies , 2007, European journal of neurology.

[38]  Y. Itoyama,et al.  Corticolimbic gray matter loss in Parkinson’s disease without dementia , 2010, European journal of neurology.

[39]  R. Albin,et al.  Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease , 2010, Brain : a journal of neurology.

[40]  B. Gulyás,et al.  Olfactory Functions Are Mediated by Parallel and Hierarchical Processing , 2000, Neuron.

[41]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[42]  Kurt Jellinger,et al.  Amygdala pathology in Parkinson's disease , 2004, Acta Neuropathologica.

[43]  Y. Itoyama,et al.  Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment , 2009, Movement disorders : official journal of the Movement Disorder Society.